Tag: Prescription Drugs
Oral Atogepant Effective for Reducing Number of Migraine Days
Results also favored atogepant over placebo for most secondary end points; constipation, nausea most common adverse events
Dexamethasone Underused for Adults Hospitalized With COVID-19
Dexamethasone and remdesivir use have gradually increased during the pandemic; hydroxychloroquine use peaked in March 2020
Exposure to Prenatal Antipsychotics Seems Safe
No increased risk seen for ADHD, ASD, small for gestational age with prenatal antipsychotics exposure
AAP: Consider Palivizumab for Atypical Interseasonal RSV
AAP strongly supports consideration of palivizumab for patients who would be candidates per current eligibility recommendations
DPP-4i Use May Protect in Alzheimer Dementia With Diabetes
Low amyloid burden and favorable cognitive outcomes seen with DPP-4i use in Alzheimer disease-related cognitive impairment with diabetes
Some Newer Antiseizure Meds May Not Increase Suicide Risk
Current evidence does not support increased suicidality for certain newer antiseizure medications; class warning may not be merited
Cabotegravir Bests TDF-FTC for HIV Prevention in Those at Risk
Long-acting injectable cabotegravir superior for preventing HIV infection in men who have sex with men, transgender women
Remetinostat Gel Promising for Basal Cell Carcinoma
Overall response rate of 69.7 percent seen with topical HDAC inhibitor; complete resolution observed for 54.8 percent of tumors on pathologic exam
Antibody Combo Prevents Infection From SARS-CoV-2 Exposure
Single dose of REGEN-COV reduces symptomatic, asymptomatic infection risk in household contacts of infected persons for 28-day period
Papers on COVID-19 in Psoriasis, Psoriatic Arthritis Carry Risk for Bias
Risk for bias high in papers relating to patients with psoriasis and psoriatic arthritis receiving biologic therapies
